NO20005556L - PTH 2 reseptor-selektive forbindelser - Google Patents

PTH 2 reseptor-selektive forbindelser

Info

Publication number
NO20005556L
NO20005556L NO20005556A NO20005556A NO20005556L NO 20005556 L NO20005556 L NO 20005556L NO 20005556 A NO20005556 A NO 20005556A NO 20005556 A NO20005556 A NO 20005556A NO 20005556 L NO20005556 L NO 20005556L
Authority
NO
Norway
Prior art keywords
pth
abnormal
selective compounds
receptor selective
functions
Prior art date
Application number
NO20005556A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005556D0 (no
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Beth Israel Hospital filed Critical Sod Conseils Rech Applic
Publication of NO20005556D0 publication Critical patent/NO20005556D0/no
Publication of NO20005556L publication Critical patent/NO20005556L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005556A 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser NO20005556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05
PCT/US1999/009521 WO1999057139A2 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Publications (2)

Publication Number Publication Date
NO20005556D0 NO20005556D0 (no) 2000-11-03
NO20005556L true NO20005556L (no) 2001-01-03

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005556A NO20005556L (no) 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser

Country Status (12)

Country Link
US (2) US7531621B1 (enExample)
EP (1) EP1075491B1 (enExample)
JP (1) JP4460157B2 (enExample)
AT (1) ATE392431T1 (enExample)
AU (1) AU3673699A (enExample)
CA (1) CA2327509A1 (enExample)
DE (1) DE69938548T2 (enExample)
ES (1) ES2302374T3 (enExample)
HU (1) HUP0300891A2 (enExample)
NO (1) NO20005556L (enExample)
PL (1) PL344645A1 (enExample)
WO (1) WO1999057139A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK40599A3 (en) 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
UA74130C2 (uk) 1997-05-15 2005-11-15 Чугаі Сейяку Кабусікі Кайся ЗАСТОСУВАННЯ АНТИТІЛА ПРОТИ БІЛКА, СПОРІДНЕНОГО З ПАРАТИРЕОЇДНИМ ГОРМОНОМ (PTHrP), АБО ЙОГО ФУНКЦІОНАЛЬНО АКТИВНОГО ФРАГМЕНТА І/АБО ЙОГО МОДИФІКОВАНОГО ФРАГМЕНТА ДЛЯ ВИРОБНИЦТВА ЛІКАРСЬКОГО ЗАСОБУ ДЛЯ ПРОФІЛАКТИКИ АБО ЛІКУВАННЯ КАХЕКСІЇ
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
CA2373885A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for diseases caused by pth or pthrp
EP1987842A1 (en) 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitor
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
CN101522709B (zh) 2006-10-13 2013-03-20 伊莱利利公司 作为pth受体调节剂的聚乙二醇化的pth及其用途
JP5711966B2 (ja) 2007-08-01 2015-05-07 ザ ジェネラル ホスピタル コーポレイション Gタンパク質共役受容体および関連組成物を使用するスクリーニング方法
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
DE68921665T2 (de) 1988-05-09 1995-09-21 Merck & Co Inc Hemmer vom flüssigen kalziumerhöhenden Faktor.
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
CA2098283A1 (en) 1990-12-21 1992-06-22 Richard P. Bozzato Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
ATE304020T1 (de) 1996-07-31 2005-09-15 Gen Hospital Corp Parathyroidhormon-verwandthe peptidanaloge

Also Published As

Publication number Publication date
US7531621B1 (en) 2009-05-12
ATE392431T1 (de) 2008-05-15
EP1075491B1 (en) 2008-04-16
WO1999057139A3 (en) 2000-02-03
DE69938548T2 (de) 2009-06-18
JP4460157B2 (ja) 2010-05-12
HUP0300891A2 (hu) 2003-07-28
DE69938548D1 (de) 2008-05-29
CA2327509A1 (en) 1999-11-11
PL344645A1 (en) 2001-11-19
WO1999057139A2 (en) 1999-11-11
NO20005556D0 (no) 2000-11-03
US20090226477A1 (en) 2009-09-10
AU3673699A (en) 1999-11-23
JP2002513801A (ja) 2002-05-14
EP1075491A2 (en) 2001-02-14
ES2302374T3 (es) 2008-07-01

Similar Documents

Publication Publication Date Title
NO20005556L (no) PTH 2 reseptor-selektive forbindelser
AU3652102A (en) Compounds and their uses
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
YU33802A (sh) Policikloalkilpurini kao antagonisti adenozinskih receptora
BRPI0517039A (pt) método de flexão de materiais folha e respectiva folha
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
SE0201448D0 (sv) Method for reducing methane production emanating from the digestive activites of an animal
MX360150B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
GB0012362D0 (en) Chemical compounds
DK1187537T3 (da) Fremgangsmåde og sammensætning til forögelse af mælkeproduktionen
DK1789019T3 (da) Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
GB9815618D0 (en) Treatment of dyskinesia
DE60313132D1 (de) Anschnittsystem für reduzierung von spritzmasseaustritt aus dem angusskanal
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
NO20022471L (no) Kontinuerlig fremgangsmåte for produksjon av individuelle flak for en kontinuerlig bane
WO1999029308A3 (de) Methode zur bekämpfung der fettleibigkeit
WO2003066004A3 (en) Therapeutic compounds
UA103594C2 (ru) Способ лечения увеита
TW200505906A (en) Selective mmp-13 inhibitors
SE9702794D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application